Scientists observe drug target that can reduce pain when activated
A research group at Hiroshima University observed a potential new target for chronic pain treatment. Further research using this receptor could lead to new, more effective drugs to use in pain-relieving treatment for chronic pain.
Conditions that cause chronic pain can be difficult to manage. These include sciatica, cancer and rheumatoid arthritis. Chronic pain mechanisms are complicated, which is one of the reasons why pain management is so difficult, explains Professor Norimitsu Morioka of the Department of Pharmacology, Graduate School of Biomedical & Health Sciences, Hiroshima University. This difficulty decreases the quality of life of patients that, in many cases, can suffer from constant pain with little to no relief. General-purpose pain-relieving medication is often ineffective. Even morphine, possibly the best painkiller according to Assistant Professor Yoki Nakamura, also of the Department of Pharmacology, can fail to inhibit pain in cancer patients.
“Chronic pain is increasing worldwide […] associated with increasing population,” warns Morioka. The increasing number of sufferers of chronic pain means the establishment of new therapeutics is urgent, hence why the results of these types of studies can have important consequences on healthcare for these patients.
Previous research had shown that activating a type of cell receptor (REV-ERBs) that sends chemical signals inside the cell to block the production of certain genes regulates pain-causing and inflammatory molecules inside the body. Such research had shown that a molecule used to ‘turn on’ the REV-ERBs had decreased the production of inflammatory molecules in immune cells but
“Nobody checked the effect of REV-ERBs agonist [stimulator] on nociceptive behaviors [pain reactions] or chronic pain so first we checked the effect of REV-ERBs agonist on chronic pain,” explains Nakamura.
Until now, research has also only looked into one type of pain model at a time. Morioka elaborates that
“I think it is not enough to reduce by one target […] I think it is important to cover a lot of molecules mediating chronic pain,” and REV-ERBs seems to be a fitting target “So it is very exciting.”
The research group applied this knowledge to determine if activating the nuclear receptor REV-ERBs in specialized spinal cord cells (astrocytes) results in pain relief in mice. The team treated mice with differing levels of pain sensitivity with molecules that turned on REV-ERBs. The molecules studied can be easily found in today’s pain-relieving drugs according to the team. To test whether there was a notable effect on pain; mice were touched with a filament on their hind paw. Pain was recorded when mice raised their paw away from the filament. Light touches made mice with chronic pain react whereas ‘normal’ mice only moved when the force was increased. Mice with chronic pain when treated with a REV-ERBs stimulator did not react to the lighter touches (depending on the type of chronic pain they had). Through these observations, the research group concluded they did not feel as much pain as the untreated mice with the same type of chronic pain.
Based on these results, the researchers believe that this new target for pain relief could benefit many types of chronic pain sufferers. They plan to perform further research and drug screening experiments to develop new drugs for various types of chronic pain relief.
Learn more: New target for chronic pain relief confirmed by scientists
The Latest on: Chronic pain relief
[google_news title=”” keyword=”chronic pain relief” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Chronic pain relief
- ‘Don’t give up hope’: FIT Physical Therapy promotes healing for life with chronic pain programon April 27, 2024 at 8:03 am
Did you know that over 50 million people nationwide (about 20% of adults) suffer from chronic pain? America has a pain crisis, and it’s only getting worse. Enter the skilled and caring experts at FIT ...
- A Predictive Healthcare Visionary Is Optimistic About Solving America’s Opioid Addiction And Chronic Pain Epidemicon April 26, 2024 at 2:20 pm
Studies found that Chronic pain is more prevalent and costly than cancer, diabetes, and heart disease combined, and its rates are rising even as other chronic ...
- Scientists Make Breakthrough in Chronic Pain Treatmenton April 26, 2024 at 7:53 am
Scientists have developed tiny robotic nerve "cuffs" to diagnose and treat neurological disorders. The flexible devices offer a safer, minimally invasive alternative to today's diagnostics and could ...
- Medtronic wins FDA approval for adjustable spine-pain implanton April 26, 2024 at 5:05 am
Medtronic said that the FDA approved its new spinal implant, which delivers a variable electrical pulse to interrupt pain signals before they reach the brain.
- The Challenges of Pain Management in Latin Americaon April 26, 2024 at 1:31 am
New evidence suggested that a section of the Latin American population may have increased sensitivity to pain, which heightens the problem of inadequate healthcare access.
- New Research Links Chronic Pain to Socioeconomic Backgroundon April 25, 2024 at 9:53 pm
New research indicates that the development of chronic musculoskeletal pain may be influenced by factors such as socioeconomic status, fear of movement, smoking, and weaker support networks. In a ...
- From a Kansan with chronic pain: It’s time for our state to embrace medical cannabison April 25, 2024 at 1:33 am
I started feeling sluggish. I felt like I had a fever, even though my temperature never topped 100 degrees. The pain in your skin when you’re feverish, the ache you feel in your joints. I felt ...
- Neuroscientists report a distinct role of touch receptors in treating chronic painon April 23, 2024 at 7:01 am
People often experience the phenomenon of injuring a hand and feeling relief from vigorously shaking it. The mechanism behind this effect is fairly well explained by the "gate control theory" of ...
- CBD Products Don't Relieve Chronic Pain After Allon April 17, 2024 at 2:16 pm
CBD has become a multibillion-dollar business promoting products for many health conditions. A newly published meta-analysis finds no evidence that CBD is effective in reducing chronic pain. Those who ...
via Bing News